Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

HB 4837 (2025-2026)

https://ontology.bommaritollc.com/id/01a0d569-acce-7569-9fa7-6e55fa9e15c9

adms:identifier	mi-legislature-measure 2025-2026/HB/4837
dcterms:temporal	Michigan Legislature, 2025-2026 session
in committee	House Committee on Regulatory Reform (2025-2026)
primary sponsor	Brad Paquette
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-4837 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-4837 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-4837
schema:legislationChanges	1978 PA 368
schema:legislationIdentifier	HB 4837
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; ivermectin; allow over-the-counter access. Amends 1978 PA 368 (MCL 333.1101 - 333.25211 ) by adding secs. 17771 & 17771a.en
schema:sponsor	Jamie Thompson Jennifer Wortz Brad Paquette Jason Woolford Mike Harris Douglas C Wozniak Jaime Greene Pat Outman Tim Kelly Tom Kunse David Prestin Gregory Markkanen
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2025-HB-4837
skos:prefLabel	HB 4837 (2025-2026)en
status	in committee
status date	2025-09-04xsd:date